Summit Therapeutics Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
SMMT Company Description
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.
SMMT Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view SMMT Smart Score
Score Breakdown
SMMT Company Description
Show More
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of SMMT by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by SMMT's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on SMMT's company Twitter account
WallStreetBets
Number of mentions of SMMT in WallStreetBets Daily Discussion
SMMT News
Recent insights relating to SMMT
CNBC Recommendations
Recent picks made for SMMT stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in SMMT
Corporate Flights
Flights by private jets registered to SMMT
Our Analysis